Published in Arch Intern Med on September 25, 2006
Fixed Dose Combination Drug (Polypill)for Secondary Cardiovascular Prevention. (FOCUS) | NCT01321255
Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50
Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med (2010) 3.57
Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery. Circulation (2015) 3.25
Aggregate national experience with the wearable cardioverter-defibrillator: event rates, compliance, and survival. J Am Coll Cardiol (2010) 3.18
Medication adherence: WHO cares? Mayo Clin Proc (2011) 2.95
A randomized controlled trial of positive-affect intervention and medication adherence in hypertensive African Americans. Arch Intern Med (2012) 2.86
Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry. Circ Cardiovasc Qual Outcomes (2011) 2.77
New prescription medication gaps: a comprehensive measure of adherence to new prescriptions. Health Serv Res (2009) 2.63
P4P4P: an agenda for research on pay-for-performance for patients. Health Aff (Millwood) (2009) 2.49
Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med (2007) 2.34
A randomized controlled trial of acupuncture in stable ischemic heart disease patients. Int J Cardiol (2014) 2.13
Association between the Part D coverage gap and adverse health outcomes. J Am Geriatr Soc (2012) 1.99
Modes of delivery for interventions to improve cardiovascular medication adherence. Am J Manag Care (2010) 1.83
Meta-analysis: impact of drug class on adherence to antihypertensives. Circulation (2011) 1.81
Exploring patients' reasons for discontinuance of heart medications. J Cardiovasc Nurs (2009) 1.78
Racial/Ethnic and gender gaps in the use of and adherence to evidence-based preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction. Circulation (2013) 1.68
Predictors of nonadherence to statins: a systematic review and meta-analysis. Ann Pharmacother (2010) 1.66
Effect of exposure to evidence-based pharmacotherapy on outcomes after acute myocardial infarction in older adults. J Am Geriatr Soc (2012) 1.58
Rationale and design of the Pharmacist Intervention for Low Literacy in Cardiovascular Disease (PILL-CVD) study. Circ Cardiovasc Qual Outcomes (2010) 1.58
Evaluating user perceptions of mobile medication management applications with older adults: a usability study. JMIR Mhealth Uhealth (2014) 1.54
Trends in adherence to secondary prevention medications in elderly post-myocardial infarction patients. Pharmacoepidemiol Drug Saf (2008) 1.45
Medication adherence: emerging use of technology. Curr Opin Cardiol (2011) 1.44
Health literacy and the quality of physician-patient communication during hospitalization. J Hosp Med (2010) 1.38
How patient cost-sharing trends affect adherence and outcomes: a literature review. P T (2012) 1.37
Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clinicoecon Outcomes Res (2011) 1.22
The 'perfect storm' and acute coronary syndrome onset: do psychosocial factors play a role? Prog Cardiovasc Dis (2013) 1.21
Long-term medication adherence after myocardial infarction: experience of a community. Am J Med (2009) 1.14
Statin use in outpatients with obstructive coronary artery disease. Circulation (2011) 1.09
Impact of statin adherence on cardiovascular disease and mortality outcomes: a systematic review. Br J Clin Pharmacol (2014) 1.09
Medication adherence after myocardial infarction: a long way left to go. J Gen Intern Med (2008) 1.01
Neighborhood income and individual education: effect on survival after myocardial infarction. Mayo Clin Proc (2008) 1.01
Rethinking adherence: a health literacy-informed model of medication self-management. J Health Commun (2013) 1.00
Individual patients hold different beliefs to prescription medications to which they persist vs nonpersist and persist vs nonfulfill. Patient Prefer Adherence (2010) 0.97
Medication adherence in heart failure. Heart Fail Rev (2007) 0.97
Patient and Partner Feedback Reports to Improve Statin Medication Adherence: A Randomized Control Trial. J Gen Intern Med (2016) 0.97
The association between socioeconomic position, use of revascularization procedures and five-year survival after recovery from acute myocardial infarction. BMC Public Health (2008) 0.96
Improving the validity of determining medication adherence from electronic health record medications orders. J Am Med Inform Assoc (2011) 0.95
Non-compliance is the predominant cause of aspirin resistance in chronic coronary arterial disease patients. J Transl Med (2008) 0.95
Bleeding complications after pacemaker or cardioverter-defibrillator implantation in patients receiving dual antiplatelet therapy: Results of a prospective, two-centre registry. Neth Heart J (2010) 0.94
Primary medication non-adherence after discharge from a general internal medicine service. PLoS One (2013) 0.92
Rationale and design of the Post-MI FREEE trial: a randomized evaluation of first-dollar drug coverage for post-myocardial infarction secondary preventive therapies. Am Heart J (2008) 0.92
Fixed-dose combination therapy and secondary cardiovascular prevention: rationale, selection of drugs and target population. Nat Clin Pract Cardiovasc Med (2008) 0.92
Patterns of statin initiation, intensification, and maximization among patients hospitalized with an acute myocardial infarction. Circulation (2014) 0.91
Aspirin adherence, depression and one-year prognosis after acute coronary syndrome. Psychother Psychosom (2011) 0.91
Long-term survival among older patients with myocardial infarction differs by educational level: results from the MONICA/KORA myocardial infarction registry. Int J Equity Health (2014) 0.90
Overcoming 'resistance' to antiplatelet therapy: targeting the issue of nonadherence. Nat Rev Cardiol (2010) 0.89
beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing. Am Heart J (2010) 0.89
Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers. Patient Prefer Adherence (2008) 0.88
β blockers and mortality after myocardial infarction in patients without heart failure: multicentre prospective cohort study. BMJ (2016) 0.87
The relationship between emergency department use and cost-related medication nonadherence among Medicare beneficiaries. Ann Emerg Med (2013) 0.87
Confronting "confounding by health system use" in Medicare Part D: comparative effectiveness of propensity score approaches to confounding adjustment. Pharmacoepidemiol Drug Saf (2012) 0.86
Hospital laboratory reporting may be a barrier to detection of 'microsize' myocardial infarction in the US: an observational study. BMC Health Serv Res (2013) 0.86
Antihypertensive drug treatment changes in the general population: the CoLaus study. BMC Pharmacol Toxicol (2014) 0.86
Comprehensive cardiovascular risk management--what does it mean in practice? Vasc Health Risk Manag (2007) 0.86
Can adherence to antihypertensive therapy be used to promote adherence to statin therapy? Patient Prefer Adherence (2009) 0.85
Medication taking in coronary artery disease: a systematic review and qualitative synthesis. Ann Fam Med (2014) 0.85
Persistence with statin therapy in Hungary. Arch Med Sci (2013) 0.83
Improving health outcomes: innovation, coverage, quality and adherence. Isr J Health Policy Res (2012) 0.83
Persistence with secondary prevention medications after acute myocardial infarction: Insights from the TRANSLATE-ACS study. Am Heart J (2015) 0.83
Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France. Eur J Clin Pharmacol (2013) 0.82
Depression and coronary heart disease. ISRN Cardiol (2012) 0.82
Drug adherence to biologic DMARDS with a special emphasis on the benefits of subcutaneous abatacept. Patient Prefer Adherence (2012) 0.82
Adherence to risk factor management instructions after acute myocardial infarction: the role of emotional support and depressive symptoms. Ann Behav Med (2012) 0.81
Scalable decision support at the point of care: a substitutable electronic health record app for monitoring medication adherence. Interact J Med Res (2013) 0.81
Medication coaching program for patients with minor stroke or TIA: a pilot study. BMC Public Health (2012) 0.81
An algorithm to identify medication nonpersistence using electronic pharmacy databases. J Am Med Inform Assoc (2015) 0.80
Present and future of secondary prevention after an acute coronary syndrome. EPMA J (2011) 0.80
Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken) (2015) 0.80
Medication Nonadherence Before Hospitalization for Acute Cardiac Events. J Health Commun (2015) 0.80
The effect of post-discharge educational intervention on patients in achieving objectives in modifiable risk factors six months after discharge following an episode of acute coronary syndrome, (CAM-2 Project): a randomized controlled trial. Health Qual Life Outcomes (2010) 0.80
Pharmacist care and the management of coronary heart disease: a systematic review of randomized controlled trials. BMC Health Serv Res (2013) 0.80
Using a collaborative research approach to develop an interdisciplinary research agenda for the study of mobile health interventions for older adults. JMIR Mhealth Uhealth (2015) 0.80
How to avoid discontinuation of antihypertensive treatment: The experience in São Paulo, Brazil. Clinics (Sao Paulo) (2010) 0.80
Cardiovascular disease medication health literacy among Indigenous peoples: design and protocol of an intervention trial in Indigenous primary care services. BMC Public Health (2014) 0.78
Evidence of poor adherence to secondary prevention after acute coronary syndromes: possible remedies through the application of new technologies. Open Heart (2015) 0.78
Perspectives of patients on factors relating to adherence to post-acute coronary syndrome medical regimens. Patient Prefer Adherence (2015) 0.77
Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data. Eur J Clin Pharmacol (2012) 0.77
Structural equation modeling of the proximal-distal continuum of adherence drivers. Patient Prefer Adherence (2012) 0.77
Impairment of aspirin antiplatelet effects by non-opioid analgesic medication. World J Cardiol (2015) 0.77
A mobile application improves therapy-adherence rates in elderly patients undergoing rehabilitation: A crossover design study comparing documentation via iPad with paper-based control. Medicine (Baltimore) (2016) 0.76
Improving medication adherence in hypercholesterolemia: challenges and solutions. Vasc Health Risk Manag (2014) 0.75
Recent hospitalization for non-coronary events and use of preventive medications for coronary artery disease: an observational cohort study. BMC Cardiovasc Disord (2011) 0.75
Does high intelligence improve prognosis? The association of intelligence with recurrence and mortality among Swedish men with coronary heart disease. J Epidemiol Community Health (2014) 0.75
Age-related differences in factors associated with the underuse of recommended medications in acute coronary syndrome patients at least one year after hospital discharge. BMC Cardiovasc Disord (2014) 0.75
Combining antihypertensive and antihyperlipidemic agents - optimizing cardiovascular risk factor management. Integr Blood Press Control (2011) 0.75
Antihypertensive therapy among newly treated patients: An analysis of adherence and cost of treatment over years. Clinicoecon Outcomes Res (2010) 0.75
The lack of aspirin resistance in patients with coronary artery disease. J Transl Med (2016) 0.75
Promoting Safe Use of Medications: Providing Medication Education to Seniors Receiving Meals on Wheels. Consult Pharm (2015) 0.75
Sensitivity of medication use to formulary controls in medicare beneficiaries: a review of the literature. Am Health Drug Benefits (2011) 0.75
Home medicines reviews following acute coronary syndrome: study protocol for a randomized controlled trial. Trials (2012) 0.75
EHR-based medication support and nurse-led medication therapy management: rationale and design for a three-arm clinic randomized trial. J Am Heart Assoc (2013) 0.75
Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. J Clin Lipidol (2010) 0.75
Cognitive dysfunction and poor health literacy are common in veterans presenting with acute coronary syndrome: insights from the MEDICATION study. Patient Prefer Adherence (2015) 0.75
Discontinuation of medications 1 month after an acute myocardial infarction increased risk for death at 12 months. ACP J Club (2007) 0.75
Unmet Needs in LDL-C Lowering: When Statins Won't Do! Drugs (2016) 0.75
Perceiving one's heart condition to be cured following hospitalization for acute coronary syndromes: Implications for patient-provider communication. Patient Educ Couns (2015) 0.75
Impact of a pharmacist-delivered discharge and follow-up intervention for patients with acute coronary syndromes in Qatar: a study protocol for a randomised controlled trial. BMJ Open (2016) 0.75
Evaluation of the Effectiveness of a Patient-Centered Educational Mailer Designed to Improve Statin Adherence: A Pragmatic Trial. EGEMS (Wash DC) (2017) 0.75
Antiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes. Patient Relat Outcome Meas (2010) 0.75
Potentially disruptive life events: what are the immediate impacts on chronic disease management? A case-crossover analysis. BMJ Open (2016) 0.75
Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med (2007) 25.17
Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA (2004) 14.05
Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation (2010) 13.28
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Association of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levels. JAMA (2013) 12.37
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation. JAMA (2008) 12.36
Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet (2009) 12.19
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 11.88
Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51
Ethical and scientific implications of the globalization of clinical research. N Engl J Med (2009) 11.42
Telemonitoring in patients with heart failure. N Engl J Med (2010) 10.82
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association. Circulation (2015) 10.14
2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation (2013) 10.07
Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med (2015) 9.70
Low diagnostic yield of elective coronary angiography. N Engl J Med (2010) 9.38
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Application of new cholesterol guidelines to a population-based sample. N Engl J Med (2014) 8.22
Sequence variants in SLITRK1 are associated with Tourette's syndrome. Science (2005) 8.20
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Door-to-balloon time and mortality among patients undergoing primary PCI. N Engl J Med (2013) 8.08
AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation (2006) 8.01
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2012) 7.94
A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers. J Clin Epidemiol (2009) 7.86
Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA (2006) 7.81
Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome. JAMA (2009) 7.78
Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med (2008) 7.75
Effect of medication nonadherence on hospitalization and mortality among patients with diabetes mellitus. Arch Intern Med (2006) 7.54
Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA (2007) 7.12
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2012) 6.94
Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA (2010) 6.91
Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis. PLoS Med (2009) 6.89
Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet (2012) 6.60
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2014) 6.55
Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis. BMJ (2012) 6.39
An administrative claims measure suitable for profiling hospital performance on the basis of 30-day all-cause readmission rates among patients with heart failure. Circ Cardiovasc Qual Outcomes (2008) 6.00
The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med (2005) 5.86
Sex-based differences in the effect of digoxin for the treatment of heart failure. N Engl J Med (2002) 5.74
Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67
Comparative effectiveness of revascularization strategies. N Engl J Med (2012) 5.49
Sex and racial differences in the management of acute myocardial infarction, 1994 through 2002. N Engl J Med (2005) 5.49
Medication adherence: its importance in cardiovascular outcomes. Circulation (2009) 5.30
Diagnoses and timing of 30-day readmissions after hospitalization for heart failure, acute myocardial infarction, or pneumonia. JAMA (2013) 5.27
Endoscopic versus open vein-graft harvesting in coronary-artery bypass surgery. N Engl J Med (2009) 5.19
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA (2011) 5.16
Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA (2003) 5.09
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Time to treatment with intravenous tissue plasminogen activator and outcome from acute ischemic stroke. JAMA (2013) 5.05
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA (2002) 4.92
Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure. JAMA (2007) 4.89
Reporting the recruitment process in clinical trials: who are these patients and how did they get there? Ann Intern Med (2002) 4.80
National trends in use of computed tomography in the emergency department. Ann Emerg Med (2011) 4.72
The ADVANTAGE seeding trial: a review of internal documents. Ann Intern Med (2008) 4.70
2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2014) 4.57
Regulatory review of novel therapeutics--comparison of three regulatory agencies. N Engl J Med (2012) 4.50
Representation of the elderly, women, and minorities in heart failure clinical trials. Arch Intern Med (2002) 4.45
The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1--coronary artery bypass grafting surgery. Ann Thorac Surg (2009) 4.39
Consequences of inadequate sign-out for patient care. Arch Intern Med (2008) 4.39
Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA (2003) 4.38
Trends in length of stay and short-term outcomes among Medicare patients hospitalized for heart failure, 1993-2006. JAMA (2010) 4.36
Risks associated with statin therapy: a systematic overview of randomized clinical trials. Circulation (2006) 4.35
Appropriateness of percutaneous coronary intervention. JAMA (2011) 4.33